COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Food and Drug Administration authorized the University of California San Francisco鈥檚 Clinical Labs at China Basin to use a new molecular-based diagnostic test for SARS-CoV-2.
The Centers for Disease Control and Prevention released guidance for emergency medical planners and health care facilities on identifying relief health care facilities, and establishing or using medical operation coordination cells to improve surge capacity and resource allocation during the COVID-鈥
The Food and Drug Administration authorized the emergency use of the BD (Becton Dickinson) Veritor System for Rapid Detection of SARS-CoV-2.
The Food and Drug Administration warned of methanol鈥檚 toxic and 鈥渘ot acceptable鈥 suitability for use as an active ingredient in hand sanitizer. Methanol is a wood alcohol more commonly used for the creation of fuel or antifreeze. FDA said it has seen an increase in methanol鈥檚 use in hand sanitizers鈥
The Food and Drug Administration and Centers for Disease Control and Prevention July 7 at 12 p.m. ET will host a webinar on decontaminating respirators for health care personnel during the COVID-19 pandemic.
The blanket data reporting exceptions and extensions implemented in March across Medicare quality reporting and value-based payment programs for hospitals expired July 1.
The Food and Drug Administration issued guidance for the development of a SARS-CoV-2 vaccine, outlining key considerations to satisfy requirements for chemistry, manufacturing and control, nonclinical and clinical data.
The Food and Drug Administration authorized the emergency use of two COVID-19 molecular diagnostic tests. The tests from Inform Diagnostics Inc. and Diagnostic Solutions Laboratory LLC detect in respiratory specimens nucleic acid from SARS-CoV-2, the virus that causes COVID-19.
SARS-CoV-2 infections may be 10 times higher than reported cases, according to new data from a Centers for Disease Control and Prevention partnership with commercial laboratories to test de-identified clinical blood specimens for antibodies in Connecticut, South Florida, the New York City area,鈥
The Food and Drug Administration added the AustinP51 emergency-use system to its list of ventilator authorized for emergency use in health care settings to treat adults during the COVID-19 pandemic.